GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alivus Life Sciences Ltd (BOM:543322) » Definitions » Cash Flow for Lease Financing

Alivus Life Sciences (BOM:543322) Cash Flow for Lease Financing : ₹0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Alivus Life Sciences Cash Flow for Lease Financing?

Alivus Life Sciences's Cash Flow for Lease Financing for the three months ended in Mar. 2025 was ₹0 Mil. Alivus Life Sciences's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2025 was ₹0 Mil.

Compared with last quarter (₹0 Mil in Dec. 2024 ), Alivus Life Sciences's Cash Flow for Lease Financing remained the same in Mar. 2025 (₹0 Mil).


Alivus Life Sciences Cash Flow for Lease Financing Historical Data

The historical data trend for Alivus Life Sciences's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alivus Life Sciences Cash Flow for Lease Financing Chart

Alivus Life Sciences Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Cash Flow for Lease Financing
Get a 7-Day Free Trial - -13.65 -11.28 -22.09 -44.86

Alivus Life Sciences Quarterly Data
Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Alivus Life Sciences Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alivus Life Sciences Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Alivus Life Sciences's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Alivus Life Sciences Business Description

Traded in Other Exchanges
Address
470, Cardinal Gracious Road, 4th Floor, OIA House, Andheri (East), Mumbai, MH, IND, 400 099
Alivus Life Sciences Ltd, formerly Glenmark Life Sciences Ltd develops, manufactures, and supplies high-quality active pharmaceutical ingredients for cardiovascular disease, central nervous system disease, pain management, diabetes, gastrointestinal disorders, anti-infectives, and other therapeutic areas.

Alivus Life Sciences Headlines

No Headlines